Sanofi signals appetite for bigger deals as new chief lifts growth targets
Sanofi (SNY) is prepared to pursue larger acquisitions as it seeks to rebuild its pipeline of experimental drugs under new chief executive Belen Garijo, after the French drugmaker raised its 2026 growth targets for the second time this…
